In our study, DNA methylation profiling was able to classify tumors previously diagnosed as MAS, ERMS or MAS/ERMS (cases which could not be confidently diagnosed as either of these tumor types due to morphological overlap) into specific clusters of MAS or SARC DICER1, highlighting the potential for molecular markers to aid tumor classification. The gene discussed is DICER1; the disease is neoplasm.